Gilead Sciences Inc
€115.9
EUR
Last updated on --.
24h volume3.34M
24h highest117.08 EUR
24h lowest115.26 EUR
24h Price movement+0.28%
GILD recent prices
24 Hours
+0.28%+€0.31745
30 days
+5.74%+€6.303
60 days
+0.09%+€0.10324
90 days
-6.05%-€7.479
Key data
Previous close115.59 EUR
Market cap139.59B EUR
Volume3.34M
P/E ratio17.610000
Dividend yield (TTM)0.02%
Dividend amount0.70545 EUR
Next ex-dividend date15 June 2026
Next payment date29 June 2026
EPS diluted (TTM)6.3834 EUR
Net income (FY)7.93B EUR
Revenue (FY)25.58B EUR
Last report date7 May 2026
About Gilead Sciences Inc
HeadquartersFOSTER CITY
Employees (FY)17.00K
Revenue per employee (FY)1.50M EUR
Net income per employee (FY)466.43K EUR
Listed onNasdaq
GILD conversion tables
 |  |
|---|---|
| 0.5 GILD | 57.95 EUR |
| 1 GILD | 115.9 EUR |
| 5 GILD | 579.53 EUR |
| 10 GILD | 1,159.07 EUR |
| |
|---|---|
| 0.5 EUR | 0.0043138 GILD |
| 1 EUR | 0.0086276 GILD |
| 5 EUR | 0.043138 GILD |
| 10 EUR | 0.086276 GILD |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
GILD is trading at €115.90, +0.28% over the last 24 hours. Track live moves on the price chart at the top of this page.
The GILD stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. GILD is currently trading at €115.90, +0.28% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on GILD price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. GILD's P/E ratio is currently 17.610000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from GILD; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against GILD's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Gilead Sciences Inc's market cap is currently 139.59B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume3.34M
24h highest117.08 EUR
24h lowest115.26 EUR
24h Price movement+0.28%
Start trade with GILD Perpetual
Sign up to trade